Prof. Dr. med. Nicolas A. Geis

Head of Cardiology Outpatient Clinic 
Department of Cardiology, Angiology, Pneumology
University Hospital Heidelberg

Research Data Warehouse (RWH)


2000 – 2007 Medical Studies,
Ruprechts-Karls University Heidelberg
01/2005 -06/2005 Karolinska Institute, Stockholm
10/ 2006 – 04/2007 University Hospital of Zürich
02/2007 – 04/2007 King´s College Hospital, London
2004 – 2008 Basic Research “Cancer Therapy / Complement System”
Since 2008 Postdoctoral Research fellow
Clinical Cardiology: Heart Valve Interventions
Molecular Cardiology: Gene Transfer
Since 2015 Medical Specialist for Internal Medicine and Cardiology
Since 2018 Senior Physician and Head of Cardiology Outpatient Clinic, University Hospital Heidelberg



2005 Best Poster Award 10th European Meeting on Complement in Human Disease
2005 Scholarship of the European Union (Socrates-reasmus-Program)
2004 – 2007 Scholarship of the “German National Academic Foundation”
2016 Travel Grant, Working Group “Interventional Cardiology” (AGIK)



Geis NA, Kiriakou C, Chorianopoulos E, Uhlmann L, Katus HA, Bekeredjian R. NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation. Clin Res Cardiol. 2018;107(9):799-806.

Geis NA, Puls M, Lubos E, Zuern CS, Franke J, Schueler R, von Bardeleben RS, Boekstegers P, Ouarrak T, Zahn R, Ince H, Senges J, Katus HA, Bekeredjian R. Safety and efficacy of MitraClipTM therapy in patients with severely impaired left ventricular ejection fraction – results from the German Transcatheter Mitral Valve Interventions (TRAMI) registry. Eur J Heart Fail. 2018; 20(3):598-608.

Geis NA, Kiriakou C, Chorianopoulos E, Pleger ST, Katus HA, Bekeredjian R. Feasibility and safety of Vitamin K antagonist mono therapy in atrial fibrillation patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2017; 12(17):2058-2066.

Geis NA, Chorianopoulos E, Kallenbach K, André F, Pleger ST, Karck M, Katus HA, Bekeredjian R. Feasibility of sheathless transfemoral aortic valve implantation in patients with small access vessel diameters. Clin Res Cardiol. 2014; 103(10):775-780.

Geis NA, Pleger ST, Chorianopoulos E, Müller OJ, Katus HA, Bekeredjian R. Feasibility and clinical benefit of a suture-mediated closure device for femoral vein access after percutaneous edge-to-edge mitral valve repair. EuroIntervention. 2014; 10(11):1346-1353.